Meningitis
📧 Sign up to get email alerts when something new happens for Meningitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Lumbar Punctures in Neonates: Improving Success Rates and Minimizing Pain [NA]
This clinical trial update reports results for a neonate lumbar puncture technique study aimed at increasing success rates and reducing pain…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Understanding the Immune Response to Two Different Meningitis Vaccines [Phase 4]
Phase 4 trial update examining the immune responses elicited by two different meningitis vaccines and how they target meningitis, meningococ…
-
CLINICAL_TRIALS trial_result · 2016-11-11Clinical Trial Update: Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children
Post-licensure safety surveillance study of Menactra given as a two-dose schedule to children; the study has completed and results were post…
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier [Phase 4]
Phase 4 trial evaluating persistence of bactericidal antibodies in adults about four years after a Menactra booster.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine [Phase 2]
Phase 2 trial evaluating the immunogenicity and safety of four formulations of the GlaxoSmithKline MenACWY-TT meningococcal conjugate vaccin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Pharmacological Study of High Doses of Ceftriaxone in Meningitidis [Phase 4]
Phase 4 pharmacological study evaluating high-dose ceftriaxone for meningitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. [Phase 3]
A Phase 3 immunogenicity and safety study of an infant meningitis vaccine given after a hepatitis B birth dose completed; the trial evaluate…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Pneumococci and Hib Vaccination After Neurotrauma or Neurosurgery [Phase 2]
A Phase 2 clinical trial evaluating pneumococcal and Hib vaccination after neurotrauma or neurosurgery to prevent meningitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26 [Phase 2]
Phase 2 study update evaluating antibody persistence and booster-dose response in individuals who received Menactra vaccination three years …
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age [Phase 4]
Phase 4 clinical trial update on Menactra in healthy infants at 9 months and co-administered with Pentacel at 15-18 months; results have bee…
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: An Alternative Booster Vaccine Against Meningitis and Ear Infections [Phase 3]
A Phase 3 trial by the University of Oxford evaluating an alternative booster vaccine against meningitis and ear infections has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections [Phase 3]
Phase 3 trial comparing cotrimoxazole to vancomycin for invasive MRSA infections has completed. It evaluated outcomes in meningitis, sepsis,…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine [Phase 3]
Phase 3 study evaluates the immunogenicity and safety of a Group A, C, Y and W135 meningococcal polysaccharide vaccine for meningitis.
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine [Phase 3]
Phase 3 trial update on immunogenicity and safety of a tetravalent meningococcal conjugate vaccine (A, C, Y, W135).
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of the meningococcal B vaccine RLP2086 in adolescents has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age [Phase 2]
Phase 2 trial update for a bivalent vaccine (Rlp2086) assessing safety, tolerability, and immunogenicity in laboratory workers aged 18-65, c…
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: Does Static Ultrasound-Preview Reduce the Incidence of Difficult Lumbar Puncture? [NA]
A terminated clinical trial evaluated whether static ultrasound preview could reduce the incidence of difficult lumbar punctures; the study …
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary Care [NA]
A completed clinical trial update focused on optimizing diagnosis and antibiotic prescribing for acutely ill children in primary care.
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis [Phase 1, Phase 2]
Phase 1/2 trial update reports pharmacokinetics and safety data for meropenem in infants under 90 days with meningitis.
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: 36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds
36-month post-marketing surveillance of Menactra in 2-10 year olds was completed, with results posted. The study assessed safety and effecti…
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Understanding the Immune Response to Meningitis Vaccines [Phase 3]
A Phase 3 clinical trial update from the University of Oxford examines the immune response to meningitis vaccines. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2014-11-26Clinical Trial Update: A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years. [Phase 2]
Phase 2 trial evaluating safety, tolerability, and immunogenicity of Repevax and rLP2086 vaccine given together in adolescents aged 11 to <1…
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine [Phase 2]
A Phase 2 study evaluated a single dose of Menactra given 4-6 years after prior Menactra vaccination; the trial is completed and results wer…
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines [Phase 4]
Phase 4 post-marketing safety study of Menactra meningococcal vaccine conducted in healthy children, adolescents, and adults in the Philippi…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine
This document reports on a descriptive, post-marketing safety study of the Menactra meningococcal conjugate vaccine, conducted by Sanofi Pas…